Clinical Trials Directory

Trials / Completed

CompletedNCT02685956

Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test

Status
Completed
Phase
Study type
Observational
Enrollment
2,295 (actual)
Sponsor
Vela Diagnostics · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the performance of the Sentosa SA HSV1/2 Qualitative PCR Test. Precision of results and concordance of results with a reference assay will be evaluated.

Detailed description

This study will utilize residual samples from male and female patients with signs and symptoms of oral or genital HSV infections. Genital samples will include internal and external genital lesions such as those collected from lesions of the anus, buttocks, vagina, labia, or penis. Oral samples will include those collected from lip, gum, and mouth lesions. For concordance testing, the sample size is based on historical study design and estimates of the expected prevalence of HSV1 and/or HSV2 in the population enrolled.

Conditions

Interventions

TypeNameDescription
DEVICEVela Sentosa SA HSV1/2 Qualitative PCR Testmedical device test using Vela Sentosa SA HSV1/2 Qualitative PCR Test

Timeline

Start date
2016-04-01
Primary completion
2017-04-07
Completion
2017-04-07
First posted
2016-02-19
Last updated
2020-06-05
Results posted
2020-06-05

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02685956. Inclusion in this directory is not an endorsement.